The initial hypothesis that an increased risk of worse outcomes in patients with Type 2 diabetes mellitus is due to increased virus interaction with ACE2 sites following glycation14, seems however to be excluded, based on the present analysis. This evidence concerns the gene ACE2 and type 2 diabetes mellitus.